(Reuters) - Salix Pharmaceuticals Ltd said the U.S. Food and Drug Administration would take more time to review the drugmaker's new treatment for HIV-related diarrhea and it now expects a regulatory decision by the end of the first quarter of 2013.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment